Dyne Therapeutics Inc. 2.97% $1.44B ...
New CEO in at Amarna. Dutch gene therapy-focused biotech Amarna Therapeutics also announced a new CEO, Dr Henk Streefkerk, who has served as the company’s medical director for the last year.
Point-of-Care Food Sensitivity Testing Market. The global point-of-care food sensitivity testing market has reached a ...
According to Future Market Insights, the global nasal allergy treatment market is poised for substantial growth, with its valuation expected to double from USD 6.6 billion in 2022 to USD 13.3 billion ...
DiveWire guarantees visibility for your news announcements through instant distribution to CFO.com’s audience and its 41,000 newsletter subscribers for 21 days.